Research progress of PPARγ regulation of cholesterol and inflammation in Alzheimer's disease

被引:6
|
作者
Gu, Lili [1 ]
Ju, Yue [1 ]
Hu, Min [1 ]
Zheng, Miao [1 ]
Li, Qin [1 ]
Zhang, Xinyue [1 ]
机构
[1] Hangzhou Med Coll, Key Lab Neuropsychiat Drug Res Zhejiang Prov, Hangzhou 310013, Peoples R China
关键词
PPAR gamma; Alzheimer's disease; Cholesterol; Inflammation; ACTIVATED-RECEPTOR-GAMMA; A-BETA CLEARANCE; NF-KAPPA-B; LIPID RAFTS; INTRACEREBRAL HEMORRHAGE; HEMATOMA RESOLUTION; THERAPEUTIC TARGET; AMYLOID-BETA; IN-VITRO; EXPRESSION;
D O I
10.1007/s11011-022-01139-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peroxidase proliferator receptors (PPARs) are defined as key sensors and regulators of cell metabolism, transcription factors activated by ligands, involved in lipid, glucose and amino acid metabolism, participating in the processes of cell differentiation, apoptosis, inflammation regulation, and acute and chronic nerve damage. Among them, PPAR gamma is expressed in different brain regions and can regulate lipid metabolism, mitochondrial disorders, oxidative stress, and cell apoptosis. It has anti-inflammatory activity and shows neuroprotection. The regulation of A beta levels in Alzheimer's disease involves cholesterol metabolism and inflammation, so this article first analyzes the biological functions of PPAR gamma, then mainly focuses on the relationship between cholesterol and inflammation and A beta, and elaborates on the regulation of PPAR gamma on key proteins and the corresponding molecules, which provides new ideas for the treatment of AD.
引用
收藏
页码:839 / 854
页数:16
相关论文
共 50 条
  • [31] Preface: Highlights of recent progress in Alzheimer's disease research
    Lahiri, DK
    CURRENT DRUG TARGETS, 2004, 5 (06)
  • [32] The Research Progress of Nrf2 in Alzheimer's Disease
    Cao Hui-Min
    Yu Gang
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2015, 42 (06) : 533 - 539
  • [33] Brain inflammation, cholesterol, and glutamate as interconnected participants in the pathology of Alzheimer's disease
    Ringheim, GE
    Szczepanik, AM
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (06) : 719 - 738
  • [34] Progress in Alzheimer's disease
    Galimberti, Daniela
    Scarpini, Elio
    JOURNAL OF NEUROLOGY, 2012, 259 (02) : 201 - 211
  • [35] Progress in Alzheimer’s disease
    Daniela Galimberti
    Elio Scarpini
    Journal of Neurology, 2012, 259 : 201 - 211
  • [36] Regulation of Cerebral Cholesterol Metabolism in Alzheimer Disease
    Reiss, Allison B.
    Voloshyna, Iryna
    JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (03) : 576 - 582
  • [37] Inflammation and Alzheimer's disease
    Jones, RW
    LANCET, 2001, 358 (9280): : 436 - 437
  • [38] Inflammation in Alzheimer's disease
    Heneka, Michael T.
    CLINICAL NEUROSCIENCE RESEARCH, 2006, 6 (05) : 247 - 260
  • [39] Inflammation and Alzheimer's Disease
    Lee, Young-Jung
    Han, Sang Bae
    Nam, Sang-Yoon
    Oh, Ki-Wan
    Hong, Jin Tae
    ARCHIVES OF PHARMACAL RESEARCH, 2010, 33 (10) : 1539 - 1556
  • [40] Inflammation and Alzheimer's disease
    de Toledo, M
    REVISTA DE NEUROLOGIA, 2006, 42 (07) : 433 - 438